95. Loos RJ, Beunen G, Fagard R, Derom C, Vlietinck R. Birth weight and body composition in young women: a prospective twin study. Am J Clin Nutr 2002; 75:676-82. 96. Gale CR, Martyn CN, Kellingray S, Eastell R, Cooper C. Intrauterine programming of adult body composition. J Clin Endocrinol Metab 2001; 86:267-72. 97. Tanner JM, Whitehouse RH. Clinical longitudi<strong>na</strong>l stan<strong>da</strong>rds for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child. 1976; 51:170-9. 98. Saenger P. Turner's syndrome. N Engl J Med 1996; 335:1749-54. 99. Ber<strong>na</strong>sconi S, Larizza D, Benso L, Volta C, Vannelli S, Milani S, et al. Turner's syndrome in Italy: familial characteristics, neo<strong>na</strong>tal <strong>da</strong>ta, stan<strong>da</strong>rds for birth weight and for height and weight from infancy to adulthood. Acta Paediatr 1994; 83:292-8. 100. Mericq V. Prematurity and insulin sensitivity. Horm Res 2006; 65:131-6. 101. Cohen A, Kauli R, Pertzelan A, Lavagetto A, Roitmano Y, Romano C, et al. Fi<strong>na</strong>l height of girls with Turner's syndrome: correlation with karyotype and parental height.Acta Paediatr 1995; 84:550-4. 102. Sobey WJ, Beer SF, Carrington CA, Clark PM, Frank BH, Gray IP, et al. Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J 1989; 260:535-41. 103. Sapin R. Insulin assays: previously known and new a<strong>na</strong>lytical features. Clin Lab 2003; 49:113-21. 104. Frontini MG, Srinivasan SR, Xu J, Berenson GS. Low birth weight and longitudi<strong>na</strong>l trends of cardiovascular risk factor variables from childhood to adolescence: the bogalusa heart study. BMC Pediatr 2004; 4:22. 105. Jaquet D, Gaboriau A, Czernichow P, Levy-Marchal C. Insulin resistance early in adulthood in subjects born with intrauterine growth retar<strong>da</strong>tion. J Clin Endocrinol Metab 2000; 85:1401-6. 106. Gravholt CH, Hjerrild BE, Mosekil<strong>de</strong> L, Hansen TK, Rasmussen LM, Frystyk J, et al. Body composition is distinctly altered in Turner syndrome: relations to glucose 66 66
metabolism, circulating adipokines, and endothelial adhesion molecules. Eur J Endocrinol 2006; 155:583-92. 107. Elsheikh M, Dunger DB, Conway GS, Wass JA. Turner's syndrome in adulthood. Endocr Rev 2002; 23:120-40. 108. Alves ST, Gallichio CT, Guimaraes MM. Insulin resistance and body composition in Turner syndrome: Effect of sequential change in the route of estrogen administration. Gynecol Endocrinol 2006; 22:590-4. 109. Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, Ermetice MN. The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract 2006; 72:219-20. 67 67
- Page 1 and 2:
Universidade Federal do Rio de Jane
- Page 3 and 4:
3 3
- Page 5 and 6:
DEDICATÓRIA Ao Adilson, pelo amor
- Page 7 and 8:
RESUMO AVALIAÇÃO DA RESISTÊNCIA
- Page 9 and 10:
SUMÁRIO 2007 1 - INTRODUÇÃO.....
- Page 11 and 12:
LISTA DE SIGLAS E ABREVIATURAS AMP
- Page 13 and 14:
Tabela 14 - Análise descritiva das
- Page 15 and 16: 1 - INTRODUÇÃO A síndrome de Tur
- Page 17 and 18: gonadal é suficientemente grave pa
- Page 19 and 20: 2.2 - Resistência Insulínica - As
- Page 21 and 22: Acredita-se que o HOMA seja uma alt
- Page 23 and 24: 2.3 - Resistência Insulínica na s
- Page 25 and 26: 2.4 - Baixo Peso ao Nascer e Altera
- Page 27 and 28: Gale e cols. avaliaram homens e mul
- Page 29 and 30: 4 - PACIENTES E MÉTODOS 4.1 - Casu
- Page 31 and 32: As pacientes foram submetidas a pun
- Page 33 and 34: 3.3.2 para análise dos dados. O cr
- Page 35 and 36: A média do peso ao nascer na casu
- Page 37 and 38: 5.2 - Avaliação do perfil clínic
- Page 39 and 40: 5.3 - Avaliação do perfil clínic
- Page 41 and 42: 5.4 - Avaliação do perfil laborat
- Page 43 and 44: 65 272 p=0,0002 Figura 3 - Valores
- Page 45 and 46: Tabela 12 - Análise estatística d
- Page 47 and 48: =0,127; p=0,39 Figura 4 - Dispersã
- Page 49 and 50: Percentil 90 2,33 HOMA-IR Figura 6
- Page 51 and 52: 43 o mosaicismo poderia justificar
- Page 53 and 54: de uso de GH nestas pacientes (9 no
- Page 55 and 56: adequado. A etiopatogenia da RI na
- Page 57 and 58: 8 - REFERÊNCIAS 1. Chromosome abno
- Page 59 and 60: 20. Manuel M, Katayama PK, Jones HW
- Page 61 and 62: 43. Cesaretti ML, Kohlmann Junior O
- Page 63 and 64: 62. Rasio E, Antaki A, Van Campenho
- Page 65: 85. Ibanez L, Jimenez R, de Zegher